Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression

被引:0
|
作者
Seiler, Jillian L. [1 ,7 ]
Zhuang, Xiaowen [3 ,5 ,6 ,7 ]
Nelson, Alexandra B. [3 ,4 ,5 ,6 ,7 ,8 ]
Lerner, Talia N. [1 ,2 ,7 ,9 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL USA
[2] Northwestern Univ Interdept Neurosci Program NUIN, Evanston, IL USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA USA
[5] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA
[6] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA USA
[7] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD USA
[8] UCSF, MC 0663,675 Nelson Rising Lane, San Francisco, CA 94158 USA
[9] Ward 5 120, 303 Chicago Ave, Chicago, IL 60611 USA
关键词
Parkinson's disease; Movement disorders; Neurodegeneration; L-DOPA; Dopamine; Substantia nigra pars compacta; Striatum; Cell types; Heterogeneity; AMINO-ACID DECARBOXYLASE; SUBSTANTIA-NIGRA; EXTRACELLULAR DOPAMINE; NEURONAL VULNERABILITY; INDUCED DYSKINESIA; NMDA-RECEPTORS; 6-OHDA LESIONS; STRIATUM; BRAIN; PLASTICITY;
D O I
10.1016/j.expneurol.2024.114693
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Dopamine neurons in the substantia nigra pars compacta (SNc) synthesize and release dopamine, a critical neurotransmitter for movement and learning. SNc dopamine neurons degenerate in Parkinson's Disease (PD), causing a host of motor and non-motor symptoms. Here, we review recent conceptual advances in our basic understanding of the dopamine system - including our rapidly advancing knowledge of dopamine neuron heterogeneity - with special attention to their importance for understanding PD. In PD patients, dopamine neuron degeneration progresses from lateral SNc to medial SNc, suggesting clinically relevant heterogeneity in dopamine neurons. With technical advances in dopamine system interrogation, we can understand the relevance of this heterogeneity for PD progression and harness it to develop new treatments.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
    Fiorenzato, Eleonora
    Antonini, Angelo
    Bisiacchi, Patrizia
    Weis, Luca
    Biundo, Roberta
    MOVEMENT DISORDERS, 2021, 36 (10) : 2303 - 2313
  • [32] Detection of dopamine transporter Parkinson's disease: A longitudinal evaluating the progression of dopaminergic denervation
    Ilgin, N
    Reich, S
    Bencherif, B
    Goldberg, P
    Stumpf, M
    Zubieta, JK
    Ravert, HT
    Forst, JJ
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 522 - 522
  • [33] Dopamine transporter and Parkinson's disease
    Nakamura, S
    Kawakami, H
    Morino, H
    Kawarai, T
    Yamashita, H
    Takahashi, T
    Mitsuoka, T
    Kaseda, Y
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 467 - 470
  • [34] Dopamine agonists for Parkinson's disease
    Sharma, J
    MacMahon, D
    Stewart, D
    LANCET, 2003, 361 (9351): : 84 - 84
  • [35] Dopamine, Parkinson's disease, and volition
    Horvitz, JC
    BEHAVIORAL AND BRAIN SCIENCES, 2002, 25 (05) : 586 - +
  • [36] Dopamine Receptors and Parkinson's Disease
    Hisahara, Shin
    Shimohama, Shun
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2011, 2011
  • [37] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
  • [38] Intracerebroventricular dopamine for Parkinson's disease
    Devos, David
    Devedjian, Jean-Christophe
    Moreau, Caroline
    ONCOTARGET, 2017, 8 (28) : 45034 - 45035
  • [39] Extrastriatal dopamine and Parkinson's disease
    Parent, A
    Cossette, M
    PARKINSON'S DISEASE, 2001, 86 : 45 - 54
  • [40] Dopamine and Parkinson's disease - Introduction
    Triarhou, LC
    DOPAMINERGIC NEURON TRANSPLANTATION IN THE WEAVER MOUSE MODEL OF PARKINSON'S DISEASE, 2002, 517 : 1 - 14